Atrial Fibrillation - Pipeline
Review, H2 2014
Summary
Global
Markets Direct's, 'Atrial Fibrillation - Pipeline Review, H2 2014', provides an
overview of the Atrial Fibrillation's therapeutic pipeline.
This
report provides comprehensive information on the therapeutic development for
Atrial Fibrillation, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the
therapeutic development for Atrial Fibrillation and special features on
late-stage and discontinued projects.
Access Full Report With TOC @ http://www.radiantinsights.com/research/atrial-fibrillation-pipeline-review-h2-2014
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct's
team. Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the profiles are
updated with the latest set of information. Additionally, processes including
live news & deals tracking, browser based alert-box and clinical trials
registries tracking ensure that the most recent developments are captured on a
real time basis.
The
report enhances decision making capabilities and help to create effective
counter strategies to gain competitive advantage. It strengthens R&D
pipelines by identifying new targets and MOAs to produce first-in-class and
best-in-class products.
Note*:
Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
-
The report provides a snapshot of the global therapeutic landscape of Atrial
Fibrillation
-
The report reviews key pipeline products under drug profile section which
includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics development for
Atrial Fibrillation and enlists all their major and minor projects
-
The report summarizes all the dormant and discontinued pipeline projects
Reasons
to buy
-
Provides strategically significant competitor information, analysis, and
insights to formulate effective R&D development strategies
-
Identify emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage
-
Develop strategic initiatives by understanding the focus areas of leading
companies
About Radiant Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision making
process. We have a comprehensive collection of reports, covering over 40 key
industries and a host of micro markets. In addition to over extensive database
of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For more information visit, Radiant
Insights
Contact Details:
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
Phone:
1-415-349-0054
Toll
Free: 1-888-202-9519
